Ligand validation:4E2X

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 4E2X designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4E2X_SAH_A_506	94%	21%	0.078	0.975	1.17	2.11	3	11	0	0	100%	1
4E33_SAH_A_502	94%	21%	0.082	0.983	1.12	2.18	2	4	0	0	100%	1
4E2Z_SAH_A_503	93%	16%	0.074	0.97	1.19	2.49	3	10	1	0	100%	1
4E2W_SAH_A_505	92%	25%	0.088	0.977	0.98	2.05	3	9	1	0	100%	1
3NDJ_SAH_A_415	91%	15%	0.081	0.966	1.26	2.44	3	7	2	0	100%	1
4E30_SAH_A_504	90%	23%	0.095	0.977	1.16	2.01	4	7	0	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.